{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:36:37Z","timestamp":1787726197185,"version":"build-2784847793"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.tjog.2023.07.034","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T22:19:22Z","timestamp":1694125162000},"page":"651-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The role of sialylation in gynecologic cancers"],"prefix":"10.1016","volume":"62","author":[{"given":"Szu-Ting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Hsien","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ling","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjog.2023.07.034_bib1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s13238-018-0597-5","article-title":"Sialylation is involved in cell fate decision during development, reprogramming and cancer progression","volume":"10","author":"Li","year":"2019","journal-title":"Protein Cell"},{"key":"10.1016\/j.tjog.2023.07.034_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10719-018-9820-0","article-title":"Serum sialylation changes in cancer","volume":"35","author":"Zhang","year":"2018","journal-title":"Glycoconj J"},{"key":"10.1016\/j.tjog.2023.07.034_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/JCMA.0000000000000252","article-title":"Aberrant sialylation in ovarian cancers","volume":"83","author":"Lee","year":"2020","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1016\/j.tjog.2023.07.034_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/JCMA.0000000000000480","article-title":"Sialylated autoantibodies involved in disease activity of rheumatoid arthritis","volume":"84","author":"Lee","year":"2021","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1016\/j.tjog.2023.07.034_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/JCMA.0000000000000096","article-title":"Aberrant sialylation of immune cells in rheumatoid arthritis","volume":"82","author":"Lee","year":"2019","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1016\/j.tjog.2023.07.034_bib6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1073\/pnas.1417508112","article-title":"A\u00a0red meat-derived glycan promotes inflammation and cancer progression","volume":"112","author":"Samraj","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tjog.2023.07.034_bib7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41416-020-01126-7","article-title":"Insights into the role of sialylation in cancer progression and metastasis","volume":"124","author":"Dobie","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.tjog.2023.07.034_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12916-020-01721-8","article-title":"Association between Neu5Gc carbohydrate and serum antibodies against it provides the molecular link to cancer: French NutriNet-Sant\u00e9 study","volume":"18","author":"Bashir","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.tjog.2023.07.034_bib9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3389\/fimmu.2019.00807","article-title":"From \"serum sickness\" to \"xenosialitis\": past, present, and future significance of the non-human sialic acid Neu5Gc","volume":"10","author":"Dhar","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.tjog.2023.07.034_bib10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in health and disease","volume":"15","author":"Reily","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.tjog.2023.07.034_bib11","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/glycob\/cws057","article-title":"Mammalian sialidases: physiological and pathological roles in cellular functions","volume":"22","author":"Miyagi","year":"2012","journal-title":"Glycobiology"},{"key":"10.1016\/j.tjog.2023.07.034_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.799861","article-title":"The distinct roles of sialyltransferases in cancer biology and onco-immunology","volume":"12","author":"Hugonnet","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.tjog.2023.07.034_bib13","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.3390\/ijms22115774","article-title":"Sialic acid-siglec Axis in human immune regulation, involvement in autoimmunity and cancer and potential therapeutic treatments","volume":"22","author":"Gianchecchi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tjog.2023.07.034_bib14","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3389\/fimmu.2018.02807","article-title":"Modulation of immune tolerance via siglec-sialic acid interactions","volume":"9","author":"L\u00fcbbers","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.tjog.2023.07.034_bib15","article-title":"The roles of Siglec7 and Siglec9 on natural killer cells in virus infection and tumour progression","volume":"2020","author":"Zheng","year":"2020","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.tjog.2023.07.034_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri2056","article-title":"Siglecs and their roles in the immune system","volume":"7","author":"Crocker","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.tjog.2023.07.034_bib17","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/biology10111178","article-title":"Siglecs as therapeutic targets in cancer","volume":"10","author":"Lim","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.tjog.2023.07.034_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790317","article-title":"Siglec signaling in the tumor microenvironment","volume":"12","author":"van Houtum","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.tjog.2023.07.034_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2022.101112","article-title":"Siglec receptors as new immune checkpoints in cancer","volume":"90","author":"Stanczak","year":"2023","journal-title":"Mol Aspect Med"},{"key":"10.1016\/j.tjog.2023.07.034_bib20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/imm.13470","article-title":"Siglec-5 is an inhibitory immune checkpoint molecule for human T cells","volume":"166","author":"Vuchkovska","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.tjog.2023.07.034_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.996746","article-title":"Siglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+ T cells with high functional and metabolic capacities","volume":"13","author":"Haas","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.tjog.2023.07.034_bib22","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10495-008-0219-4","article-title":"Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced mitochondrial pathway to apoptosis and caspase activation is potentiated by phospholipid scramblase-3","volume":"13","author":"Ndebele","year":"2008","journal-title":"Apoptosis"},{"key":"10.1016\/j.tjog.2023.07.034_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)80984-8","article-title":"TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways","volume":"84","author":"Hsu","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.tjog.2023.07.034_bib24","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1074\/jbc.M117.801480","article-title":"ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation\u00a0of\u00a0the\u00a0TNF receptor 1 (TNFR1) death receptor","volume":"293","author":"Holdbrooks","year":"2018","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.tjog.2023.07.034_bib25","doi-asserted-by":"crossref","first-page":"22982","DOI":"10.1074\/jbc.M110.211375","article-title":"Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells","volume":"286","author":"Swindall","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.tjog.2023.07.034_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40364-023-00466-9","article-title":"Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy","volume":"11","author":"Liu","year":"2023","journal-title":"Biomark Res"},{"key":"10.1016\/j.tjog.2023.07.034_bib27","doi-asserted-by":"crossref","first-page":"20249","DOI":"10.1074\/jbc.RA118.004636","article-title":"Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin-glycan specificities in a natural context","volume":"293","author":"Nielsen","year":"2018","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.tjog.2023.07.034_bib28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bbamcr.2015.08.008","article-title":"Galectin 3 as a guardian of the tumor microenvironment","volume":"1863","author":"Ruvolo","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.tjog.2023.07.034_bib29","first-page":"8302","article-title":"CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis","volume":"63","author":"Fukumori","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.tjog.2023.07.034_bib30","doi-asserted-by":"crossref","first-page":"22177","DOI":"10.1074\/jbc.M800015200","article-title":"Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis","volume":"283","author":"Zhuo","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.tjog.2023.07.034_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.cellbio.042308.113238","article-title":"Rolling cell adhesion","volume":"26","author":"McEver","year":"2010","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.tjog.2023.07.034_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35010517","article-title":"FAK integrates growth-factor and integrin signals to promote cell migration","volume":"2","author":"Sieg","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.tjog.2023.07.034_bib33","doi-asserted-by":"crossref","first-page":"12000","DOI":"10.1074\/jbc.M115.636969","article-title":"Dynamic sialylation in transforming growth factor-\u03b2 (TGF-\u03b2)-induced epithelial to mesenchymal transition","volume":"290","author":"Du","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.tjog.2023.07.034_bib34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/gyno.2001.6358","article-title":"Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix","volume":"83","author":"Wang","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2023.07.034_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.2002.6714","article-title":"Expression of sialyltransferase family members in cervix squamous cell carcinoma correlates with lymph node metastasis","volume":"86","author":"Wang","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2023.07.034_bib36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0090-8258(03)00127-6","article-title":"Enhanced expression of alpha 2,6-sialyltransferase ST6Gal I in cervical squamous cell carcinoma","volume":"89","author":"Wang","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2023.07.034_bib37","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1186\/s12885-016-2981-y","article-title":"Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tjog.2023.07.034_bib38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/JCMA.0000000000000945","article-title":"To explore the effects of herbal medicine among cancer patients in Taiwan: a cohort study","volume":"86","author":"Li","year":"2023","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1016\/j.tjog.2023.07.034_bib39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/JCMA.0000000000000643","article-title":"Comparing paclitaxel-platinum with ifosfamide-platinum as the front-line chemotherapy for patients with advanced-stage uterine carcinosarcoma","volume":"85","author":"Su","year":"2022","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1016\/j.tjog.2023.07.034_bib40","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tjog.2022.08.021","volume":"62","author":"Lee","year":"2023","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2023.07.034_bib41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tjog.2022.09.015","article-title":"Mismatch repair protein deficiency in endometriosis: precursor of endometriosis-associated ovarian cancer in women with lynch syndrome","volume":"62","author":"Yamaguchi","year":"2023","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2023.07.034_bib42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tjog.2022.09.009","article-title":"A\u00a0novel necroptosis-associated miRNA signature predicting prognosis of endometrial cancer and correlated with immune infiltration","volume":"62","author":"Ye","year":"2023","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2023.07.034_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tjog.2022.10.005","article-title":"Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: a new potential biomarker and therapeutic target","volume":"62","author":"Zhang","year":"2023","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2023.07.034_bib44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.tjog.2022.07.010","article-title":"Validation of multi-gene panel next-generation sequencing for the detection of BRCA mutation in formalin-fixed, paraffin-embedded epithelial ovarian cancer tissues","volume":"62","author":"Kim","year":"2023","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2023.07.034_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tjog.2022.09.006","article-title":"Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer","volume":"62","author":"Byun","year":"2023","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2023.07.034_bib46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ygyno.2005.07.016","article-title":"Altered mRNA expressions of sialyltransferases in ovarian cancers","volume":"99","author":"Wang","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2023.07.034_bib47","doi-asserted-by":"crossref","first-page":"29013","DOI":"10.18632\/oncotarget.15994","article-title":"\u03b12,3-sialyltransferase type I regulates migration and peritoneal dissemination of ovarian cancer cells","volume":"8","author":"Wen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tjog.2023.07.034_bib48","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1006\/bbrc.2001.5002","article-title":"Soyasaponin I, a potent and specific sialyltransferase inhibitor","volume":"284","author":"Wu","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.tjog.2023.07.034_bib49","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41419-018-1101-0","article-title":"Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-\u03b21-induced EMT and confers paclitaxel resistance in ovarian cancer","volume":"9","author":"Wu","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.tjog.2023.07.034_bib50","first-page":"3","article-title":"ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function","volume":"1","author":"Christie","year":"2008","journal-title":"J\u00a0Ovarian Res"},{"key":"10.1016\/j.tjog.2023.07.034_bib51","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.tjog.2022.09.001","article-title":"Endometrial cancer: Part I. Basic concept","volume":"61","author":"Wang","year":"2022","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2023.07.034_bib52","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.tjog.2022.04.009","article-title":"Association of immunohistochemical profiles with histotypes in endometrial carcinomas","volume":"61","author":"Lin","year":"2022","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2023.07.034_bib53","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.tjog.2022.06.005","article-title":"Prognostic impact of adding bevacizumab to carboplatin and paclitaxel for recurrent, persistent, or metastatic cervical cancer","volume":"61","author":"Yasunaga","year":"2022","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2023.07.034_bib54","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.tjog.2022.04.005","article-title":"Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes","volume":"61","author":"Liu","year":"2022","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2023.07.034_bib55","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/JCMA.0000000000000910","article-title":"A\u00a0retrospective cohort study on the cardiotoxicity incidence rates of immune checkpoint inhibitors for oncology patients","volume":"86","author":"Ho","year":"2023","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1016\/j.tjog.2023.07.034_bib56","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/JCMA.0000000000000893","article-title":"Preliminary outcomes of accelerated partial breast irradiation by interstitial multicatheter brachytherapy with intraoperative free-hand catheter implantation in early breast cancer","volume":"86","author":"Cheng","year":"2023","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1016\/j.tjog.2023.07.034_bib57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0301-2115(97)00176-0","article-title":"Sialic acid concentration in serum and tissue of endometrial cancer patients","volume":"76","author":"Paszkowska","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.tjog.2023.07.034_bib58","first-page":"459","article-title":"Total sialic acid content in endometrial cancer tissue in relation to normal and hyperplastic human endometrium","volume":"24","author":"Paszkowska","year":"2000","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.tjog.2023.07.034_bib59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/ijms17030275","article-title":"The role of sialyl-tn in cancer","volume":"17","author":"Munkley","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tjog.2023.07.034_bib60","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12253-015-0030-9","article-title":"Serum sialyl-tn (STN) as a tumor marker in patients with endometrial cancer","volume":"22","author":"Hashiguchi","year":"2016","journal-title":"Pathol Oncol Res"}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455923002073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455923002073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:22:12Z","timestamp":1760898132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455923002073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1028455923002073"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2023.07.034","relation":{},"ISSN":["1028-4559"],"issn-type":[{"value":"1028-4559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of sialylation in gynecologic cancers","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2023.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}